Markets:

Overview

News

Currencies

International

Treasuries

Rezolute, Inc. - Common Stock (NV) (NQ:RZLT)

5.020 +0.090 (+1.83%)

Streaming Delayed Price Updated: 12:50 PM EDT, Jul 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Rezolute, Inc. - Common Stock (NV)

< Previous 1 2 3 4 Next >

Which stocks are gapping on Wednesday? ↗

March 25, 2026

Via Chartmill

Insiders Made Their Bets in 2025—These Were the Top 5 Stocks They Bought ↗

December 30, 2025

Insiders bought these stocks heavily in 2025, but investors should be wary; only some of them are good buys for 2026 portfolios.

Via MarketBeat

Topics Artificial Intelligence

Which stocks are gapping on Wednesday? ↗

December 24, 2025

Traders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps.

Via Chartmill

On Wednesday, there are stocks with unusual volume. Let's take a look. ↗

December 17, 2025

In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.

Via Chartmill

Unusual volume stocks in Monday's session ↗

December 15, 2025

Let's have a look at what is happening on the US markets on Monday. Below you can find the stocks with an unusual volume in today's session.

Via Chartmill

Unusual volume stocks in Friday's session ↗

December 12, 2025

Unusual volume stocks are being observed in Friday's session.

Via Chartmill

RZLT Stock Lost Nearly 90% Of Its Value Today – What Did The Company’s Latest Trial Reveal? ↗

December 11, 2025

Rezolute said that its Phase 3 sunRIZE trial of ersodetug to treat low blood pressure failed to meet its primary endpoint.

Via Stocktwits

10 Health Care Stocks Whale Activity In Today's Session ↗

October 06, 2025

Via Benzinga

Rezolute Inc (NASDAQ:RZLT) Reports Q4 FY2025 Results, Posts Wider-Than-Expected Loss Amid Strong Clinical Progress ↗

September 17, 2025

Rezolute Inc. reports Q4 FY2025 results, posting a net loss but maintaining a strong cash position of $167.9M to fund its Phase 3 clinical trials for congenital and tumor hyperinsulinism.

Via Chartmill

Rezolute Stock: FDA Fast Track Fuels 2025 Breakout ↗

September 17, 2025

Rezolute, Inc. is on track for its lead candidate to hit blockbuster status, but there are still risks and hurdles to overcome.

Via MarketBeat

10 Health Care Stocks Whale Activity In Today's Session ↗

August 13, 2025

Via Benzinga

Rezolute 'Thrilled' With Positive Review Of Genetic Disorder Trial, Expects Topline Results In December ↗

April 23, 2025

Rezolute advances HI drug trial after DMC review and secures $90 million in funding through stock offering to support development.

Via Benzinga

The market is filled with gapping stocks in Wednesday's session. ↗

April 23, 2025

The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

What's going on in today's pre-market session ↗

April 23, 2025

Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 23, 2025

Via Benzinga

Top movers analysis in the middle of the day on 2025-04-21: top gainers and losers in today's session. ↗

April 21, 2025

Looking for insights into the US markets in the middle of the day on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 21, 2025

Via Benzinga

Why AZEK Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗

March 24, 2025

Via Benzinga

FDA Gives Green Signal To Rezolute's Genetic Disorder Treatment ↗

September 09, 2024

FDA lifts clinical hold on Rezolute's RZ358 for treating congenital hyperinsulinism, allowing U.S. participants in Phase 3 study. Enrollment expected to start in 2025 with topline data by mid-year.

Via Benzinga

Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 14, 2024

Via Benzinga

Why Adobe Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗

June 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 14, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

June 14, 2024

Pre-market stock movers are worth checking out on Friday as we dive into all of the biggest news moving shares this morning!

Via InvestorPlace

Adobe, Avidity Biosciences And 3 Stocks To Watch Heading Into Friday ↗

June 14, 2024

Via Benzinga

RH Posts Mixed Q1 Results, Joins MSC Industrial Direct And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

June 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 13, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

June 12, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

June 07, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 05, 2024

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.